← All trials
NCT05156541
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 18, 2009
- Primary completion
- Jun 30, 2010
- Completion date
- Jul 15, 2010
- First posted
- Dec 14, 2021
- Last posted
- Dec 14, 2021
- Enrollment
- 30
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- City Clinical Hospital named after M.E. ZhadkevichLead sponsor
- City Clinical Hospital named after M.E. ZhadkevichStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.